US Stock MarketDetailed Quotes

AIFF Firefly Neuroscience

Watchlist
  • 3.010
  • -0.080-2.59%
Close Nov 1 16:00 ET
  • 3.010
  • 0.0000.00%
Post 19:10 ET
25.16MMarket Cap-5280P/E (TTM)

Firefly Neuroscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-201.57K
24.29%-2.89M
-452K
-3.82M
Net income from continuing operations
---746.83K
13.51%-3.79M
---802K
---4.38M
Operating gains losses
----
93.17%-28K
--0
---410K
Depreciation and amortization
---171.87K
-96.74%14K
--0
--429K
Other non cash items
----
262.20%460K
--0
--127K
Change In working capital
---303.12K
302.59%391K
--314K
---193K
-Change in receivables
--82.39K
3.85%27K
--7K
--26K
-Change in prepaid assets
--39.56K
-77.36%12K
--17K
--53K
-Change in payables and accrued expense
---128.5K
-200.00%-98K
--140K
--98K
-Change in other working capital
---339.25K
221.62%450K
--150K
---370K
Cash from discontinued investing activities
Operating cash flow
--491.54K
24.29%-2.89M
---452K
---3.82M
Investing cash flow
Cash flow from continuing investing activities
-935.97K
-83.59%262K
0
1.6M
Net PPE purchase and sale
----
-56.11%262K
--0
--597K
Net investment purchase and sale
----
--0
----
--1M
Cash from discontinued investing activities
Investing cash flow
---935.97K
-83.59%262K
--0
--1.6M
Financing cash flow
Cash flow from continuing financing activities
1.67M
-0.34%2.04M
244K
2.04M
Net issuance payments of debt
---761.12K
-14.54%1.75M
---6K
--2.04M
Net common stock issuance
--2.44M
--290K
--250K
--0
Cash from discontinued financing activities
Financing cash flow
--1.67M
-0.34%2.04M
--244K
--2.04M
Net cash flow
Beginning cash position
--338.3K
-21.70%653K
--266K
--834K
Current changes in cash
--1.23M
-228.73%-595K
---208K
---181K
End cash Position
--893K
-91.12%58K
--58K
--653K
Free cash flow
--491.54K
24.29%-2.89M
---452K
---3.82M
Currency Unit
USD
USD
USD
USD
(Q3)Sep 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -201.57K24.29%-2.89M-452K-3.82M
Net income from continuing operations ---746.83K13.51%-3.79M---802K---4.38M
Operating gains losses ----93.17%-28K--0---410K
Depreciation and amortization ---171.87K-96.74%14K--0--429K
Other non cash items ----262.20%460K--0--127K
Change In working capital ---303.12K302.59%391K--314K---193K
-Change in receivables --82.39K3.85%27K--7K--26K
-Change in prepaid assets --39.56K-77.36%12K--17K--53K
-Change in payables and accrued expense ---128.5K-200.00%-98K--140K--98K
-Change in other working capital ---339.25K221.62%450K--150K---370K
Cash from discontinued investing activities
Operating cash flow --491.54K24.29%-2.89M---452K---3.82M
Investing cash flow
Cash flow from continuing investing activities -935.97K-83.59%262K01.6M
Net PPE purchase and sale -----56.11%262K--0--597K
Net investment purchase and sale ------0------1M
Cash from discontinued investing activities
Investing cash flow ---935.97K-83.59%262K--0--1.6M
Financing cash flow
Cash flow from continuing financing activities 1.67M-0.34%2.04M244K2.04M
Net issuance payments of debt ---761.12K-14.54%1.75M---6K--2.04M
Net common stock issuance --2.44M--290K--250K--0
Cash from discontinued financing activities
Financing cash flow --1.67M-0.34%2.04M--244K--2.04M
Net cash flow
Beginning cash position --338.3K-21.70%653K--266K--834K
Current changes in cash --1.23M-228.73%-595K---208K---181K
End cash Position --893K-91.12%58K--58K--653K
Free cash flow --491.54K24.29%-2.89M---452K---3.82M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data